CORBO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 4.247
EU - Europa 2.118
AS - Asia 1.661
SA - Sud America 76
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 8.126
Nazione #
US - Stati Uniti d'America 4.219
CN - Cina 706
RU - Federazione Russa 512
SG - Singapore 450
IT - Italia 419
HK - Hong Kong 358
DE - Germania 344
IE - Irlanda 287
SE - Svezia 236
GB - Regno Unito 104
UA - Ucraina 83
BR - Brasile 62
FR - Francia 36
ID - Indonesia 32
NL - Olanda 28
VN - Vietnam 24
CA - Canada 22
JP - Giappone 20
IN - India 17
FI - Finlandia 16
AT - Austria 12
DK - Danimarca 12
TR - Turchia 12
ZA - Sudafrica 12
IR - Iran 8
TW - Taiwan 8
ES - Italia 7
PK - Pakistan 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
EU - Europa 5
MX - Messico 5
PT - Portogallo 5
AR - Argentina 4
EG - Egitto 3
PL - Polonia 3
UZ - Uzbekistan 3
BD - Bangladesh 2
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
KR - Corea 2
PH - Filippine 2
RO - Romania 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CO - Colombia 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
MA - Marocco 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
VE - Venezuela 1
Totale 8.126
Città #
Ann Arbor 792
Fairfield 491
Hong Kong 323
Singapore 310
Wilmington 292
Dublin 283
Frankfurt am Main 276
Ashburn 256
Chandler 227
Seattle 226
Woodbridge 214
Dearborn 207
Houston 203
Cambridge 165
Milan 156
Princeton 134
Santa Clara 114
New York 102
Qingdao 80
Altamura 64
Moscow 64
Nanjing 63
Jacksonville 59
Lawrence 56
Beijing 54
Shanghai 48
San Diego 35
Guangzhou 27
Hangzhou 26
Andover 25
Jakarta 25
London 22
Hefei 17
Hebei 15
Nanchang 15
Shenyang 15
Tokyo 15
Xi'an 14
Council Bluffs 13
Dong Ket 12
Parma 11
Kocaeli 10
Los Angeles 10
Nuremberg 10
Shenzhen 10
Tianjin 10
Changsha 9
Chengdu 9
Chicago 9
Dallas 9
Jiaxing 9
Naples 9
Düsseldorf 8
Norwalk 8
Turku 8
Wuhan 8
Zhengzhou 8
Bologna 7
Central 7
Meishan 7
Modena 7
Munich 7
Rome 7
Toronto 7
São Paulo 6
Vienna 6
Boardman 5
Brno 5
Chongqing 5
Collesalvetti 5
Edmonton 5
Genoa 5
Pavia 5
Torino 5
Amsterdam 4
Falkenstein 4
Fuzhou 4
Hamburg 4
Ho Chi Minh City 4
Jinan 4
Kilburn 4
Melzo 4
Montlhéry 4
Phoenix 4
Sacramento 4
San Mateo 4
Storrs 4
Taipei 4
Trescore Cremasco 4
Ulm 4
Washington 4
Almere Stad 3
Bari 3
Bastiglia 3
Belfast 3
Calgary 3
Carate Brianza 3
Chiavari 3
Empoli 3
Falls Church 3
Totale 5.886
Nome #
Macrophage Cell Membrane-Cloaked Nanoplatforms for Biomedical Applications 637
Mesenchymal Stromal Cell-Mediated Treatment of Local and Systemic Inflammation through the Triggering of an Anti-Inflammatory Response 227
Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma 221
Analysis of the Human Plasma Proteome Using Multi‐Nanoparticle Protein Corona for Detection of Alzheimer's Disease 219
Biomimetic Nanoparticles Potentiate the Anti-Inflammatory Properties of Dexamethasone and Reduce the Cytokine Storm Syndrome: An Additional Weapon against COVID-19? 208
Impact of plasma concentration of transferrin on targeting capacity of nanoparticles 185
Exosome-like nanovectors for drug delivery in cancer 174
Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach 162
Macrophage-derived nanovesicles exert intrinsic anti-inflammatory properties and prolong survival in sepsis through a direct interaction with macrophages 161
Laser irradiation affects the biological identity and cellular uptake of plasmonic nanoparticles 152
Biohybrid Nanoparticles to Negotiate with Biological Barriers 150
Flat Cell Culturing Surface May Cause Misinterpretation of Cellular Uptake of Nanoparticles 144
Immunoengineering in glioblastoma imaging and therapy 144
Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery 135
Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases 129
Oncoproteomic approaches to cancer marker discovery: The case of colorectal cancer 127
Nanoparticle protein corona evolution: from biological impact to biomarker discovery 127
Surface proteomic analysis of differentiated versus stem-like osteosarcoma human cells 126
Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer 125
Inflammation and Cancer: In Medio Stat Nano 122
Carcinoembryonic antigen family cell adhesion molecules (CEACAM) as colorectal cancer biomarkers 122
Biomimetic immunomodulation by crosstalk with nanoparticulate regulatory T cells 122
SRp20: an overview of its role in human diseases 120
Biomimetic proteolipid vesicles for targeting inflamed tissues 119
Case Study: Application of leukoLike technology to camouflage nanoparticles from the immune recognition 117
Quantitative identification of protein nitration sites 115
CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo 114
The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery 111
Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity 110
Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation 109
Immune tuning scaffold for the local induction of a pro-regenerative environment 109
Differential proteomic analysis in human cells subjected to ribosomal stress 107
One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA 106
Bromelain surface modification increases the diffusion of silica nanoparticles in the tumor extracellular matrix 106
Personalized protein corona on nanoparticles and its clinical implications 106
Emerging biomimetic nanotechnology in orthopedic diseases: progress, challenges, and opportunities 104
Proteomic profiling of a biomimetic drug delivery platform 103
Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability 102
Vascular Inflammation: A Novel Access Route for Nanomedicine 102
Cell source determines the immunological impact of biomimetic nanoparticles 101
The Proteomic Signature Of The Leukolike Vector Unveils The Presence Of Molecules Able To Improve Self-Tolerance Of The Drug Delivery Systems 96
Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers 96
Effects of the protein corona on liposome-liposome and liposome-cell interactions 93
Mice deficient for G-protein coupled receptor 75 display altered presynaptic structural protein expression and disrupted fear conditioning recall 91
Comparative proteomics of CD133+and CD133-colon cancer cells reveals activation of the Wnt pathway and a potential therapeutic role of SRp20 90
Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model 89
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 87
Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers 86
Biohybrid LeukoLike vector molecular characterization to improve the therapeutic efficacy and biocompatibility of current drug delivery systems 84
Biomimetic liposomal formulations to target tumor blood vessels 82
Protein Corona Sensor Array Nanosystem for Detection of Coronary Artery Disease 81
Il pattern di espressione proteica di cellule CD133+ di cancro del colon indica attivazione del pathway di WNT e probabile alterazione del meccanismo di splicing 80
Leukosomes for the targeted treatment of inflamed vasculature and atherosclerotic plaques 78
Comparative proteomics of CD133+and CD133-colon cancer cells reveals activation of the Wnt pathway and a potential therapeutic role of SRp20 75
Gaining insight into the molecular basis of brain damage in the PKU mouse model 73
Bioengineered Nanoporous Silicon with Leukocyte Membrane Promotes Endothelial Adhesion 72
The Leukosome: A biomimetic liposome for the targeting of inflamed tumor vasculature 71
Gaining insights into the role of tumor initiating cells in colon cancer by a multitask approach 71
Expanding the role of iTRAQ chemistry : quantitative analysis of post-translational modifications 70
Identification of a binding site of the human immunodeficiency virus envelope protein gp120 to neuronal-specific tubulin 69
Membrane source determines fate of biomimetic particle 67
Leukolike Vectors: leukocyte-inspired nanoparticles 67
The proteomic profiling of biomimetic drug delivery platform reveals the presence of molecules able to improve targeting ability and self-tolerance 66
Targeted delivery of protein arginine deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity 66
Membrane proteins of leukocyte-inspired nanoparticles improve their therapeutic efficacy 61
Biomimetic approaches for tissue healing and restoration. 60
Bioinspired Material Design to Tune Inflammation towards Tissue Restoration 59
Editorial: Interactions of nanoparticles with and within living organisms-What can we learn to improve efficacy of nanomedicine? 58
Unveiling the protein signature of the human osteosarcoma 3AB-OS cancer stem cell line 58
Leukosomes targeting of inflamed endothelia and platelets for atherosclerotic plaque therapy 57
The clonal hematopoiesis mutation Jak2 aggravates endothelial injury and thrombosis in arteries with erosion-like intimas 52
Biomimetic proteo-lipid vesicles for the treatment of melanoma 50
Extended cytometric characterization of colon cancer stem cell subpopulations from fresh tissue biopsies: a prerequisite for in vivo studies 49
Biomimetic carriers modulate tumor vascular barrier function 48
The protein expression pattern of CD133+ colon cancer cells indicates activation of the Wnt pathway and potential alteration of splicing mechanisms 41
RNA therapies for musculoskeletal conditions 37
The protein expression pattern of CD133+ colon cancer cells indicates activation of the Wnt pathway and potential alteration of splicing mechanisms 37
Biomaterials and nanomedicine for bone regeneration: Progress and future prospects 33
New applications of iTRAQ in protein chemistry and proteomics 30
Could selection of biomolecular corona constituents through nanoparticle design produce more effective localized therapies? 24
A Protein Corona‐Based Diagnostic Tool for Eroded Atherosclerotic Plaques 8
System, assay and method for partitioning proteins 3
Totale 8.545
Categoria #
all - tutte 35.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.414


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202080 0 0 0 0 0 0 0 0 0 0 50 30
2020/20211.219 38 46 119 149 177 115 81 168 61 103 86 76
2021/2022748 63 80 73 83 56 46 44 38 46 20 81 118
2022/20231.235 166 325 150 77 92 174 22 64 82 20 26 37
2023/20241.204 45 39 23 116 156 217 187 78 117 71 31 124
2024/20252.112 169 290 82 113 186 91 231 86 325 386 153 0
Totale 8.545